Diabetes damages nearly every organ system in the body when blood sugar stays elevated over months and years. The complications range from well-known problems like blindness, kidney failure, and heart attack to less publicized ones like joint stiffness, gum disease, dementia, and liver scarring. What ties most of them together is a common thread of blood vessel injury and nerve damage driven by prolonged exposure to high glucose. Understanding how this damage unfolds, and where it shows up, matters because many complications develop silently before symptoms appear.
How High Blood Sugar Injures Blood Vessels
Most long-term diabetes complications trace back to the same underlying process. Excess glucose in the bloodstream reacts with proteins and fats to form compounds called advanced glycation end-products, or AGEs. These AGEs accumulate in vessel walls and tissues over time, and when they bind to receptors on cells lining blood vessels, they trigger inflammation, increase the vessels’ leakiness, and promote clotting. Animal studies show that blocking this receptor interaction corrects the abnormal vessel permeability seen in diabetic models, strongly suggesting the AGE-receptor pathway plays a central role in vascular injury.1PubMed. Diabetes, advanced glycation endproducts and vascular disease AGEs also generate oxidative stress, which feeds back into more inflammation and further accelerates damage, creating a self-reinforcing cycle that worsens as diabetes duration increases.2PubMed. Role of advanced glycation end products (AGEs) and oxidative stress in vascular complications in diabetes
This vascular injury plays out differently depending on the size of the blood vessels involved. Damage to small vessels, called microvascular disease, is behind the classic triad of eye, kidney, and nerve complications. Damage to large vessels, or macrovascular disease, drives heart attacks, strokes, and poor circulation in the legs. Both processes can run in parallel, and many people with diabetes develop complications in multiple organ systems simultaneously.
Eyes and Diabetic Retinopathy
The retina depends on a dense network of tiny blood vessels, making it especially vulnerable. Early in the disease, high glucose and AGE accumulation cause the loss of pericytes, the supportive cells that wrap around capillaries and keep them stable. Once pericytes die off, the remaining vessel lining loses its normal growth regulation and can sprout fragile new vessels that leak blood and fluid into the retina.3PubMed. Pericyte loss in diabetic retinopathy: mechanisms and consequences This process, called proliferative retinopathy, is a leading cause of vision loss in working-age adults. Research in animal models has shown that drugs targeting the growth factor signals driving pericyte loss can improve pericyte survival and slow the progression of early retinal disease.4BMJ Open Diabetes Research & Care. Aflibercept ameliorates retinal pericyte loss and restores perfusion in streptozotocin-induced diabetic mice
Retinopathy is treatable when caught early, which is why annual dilated eye exams are standard for anyone with diabetes. Laser therapy, injectable medications, and surgery can preserve vision, but none of these interventions reverse damage that has already occurred. The most effective strategy remains preventing retinopathy from progressing in the first place by keeping blood sugar and blood pressure well controlled.
Kidney Disease
Diabetic kidney disease follows a recognizable trajectory. In the early stages, the kidneys actually work harder than normal, a state called hyperfiltration. This may sound benign, but it is a warning sign. A study of people with type 2 diabetes found that about 15% had hyperfiltration, and those whose kidneys stayed in that overdriven state were roughly twice as likely to progress to more advanced kidney damage compared with those whose hyperfiltration resolved.5PubMed Central. Glomerular Hyperfiltration and Renal Disease Progression in Type 2 Diabetes Over time, the kidney’s filtering units become scarred, protein starts leaking into the urine, and kidney function declines. Without intervention, this can progress to end-stage kidney disease requiring dialysis or transplant.
Blood pressure control is at least as important as blood sugar management for protecting the kidneys. Medications that block the renin-angiotensin system have long been a cornerstone. More recently, newer drug classes have shown additional kidney-protective effects beyond glucose lowering, which we will return to later in this article.
Nerve Damage
Diabetic neuropathy is among the most common complications and one of the most difficult to treat once established. The characteristic pattern involves the longest nerve fibers first, which is why symptoms typically start in the feet and progress upward. Loss of sensation, tingling, burning pain, and muscle weakness are hallmarks. Microscopic examination of affected nerves shows degeneration of sensory fibers, loss of axons, and damage to the tiny blood vessels that supply the nerves themselves.6PubMed Central. Mechanism of diabetic neuropathy: Where are we now and where to go?
The consequences of neuropathy extend well beyond discomfort. Numb feet are the primary driver of diabetic foot ulcers, because people cannot feel blisters, cuts, or pressure sores developing. When neuropathy combines with poor circulation from peripheral arterial disease, even minor wounds can become limb-threatening infections.7PubMed. Peripheral Arterial Disease, Foot Ulcers, Lower Extremity Amputations, and Diabetes Diabetes duration, blood sugar control, and self-care habits all influence who develops foot complications and who does not. Daily foot inspection sounds mundane, but it remains one of the most effective ways to catch problems before they become emergencies.
Heart Disease and Stroke
Cardiovascular disease is the leading cause of death among people with diabetes. Both type 1 and type 2 diabetes accelerate atherosclerosis, the buildup of fatty plaques in artery walls.8PubMed Central. The Diabetes Mellitus-Atherosclerosis Connection: The Role of Lipid and Glucose Metabolism and Chronic Inflammation The mechanisms overlap with those driving microvascular disease: chronic inflammation, oxidative stress, and disrupted fat metabolism all contribute. But the consequences are distinct. Heart attacks occur when plaques rupture in the coronary arteries, and strokes occur when the same process affects arteries supplying the brain.
A nationwide Swedish cohort study quantified stroke risk in both diabetes types. People with type 1 diabetes had roughly two and a half times the risk of ischemic stroke compared with matched controls, while those with type 2 diabetes had about 37% higher risk. Higher average blood sugar levels were linked to greater stroke risk in both groups.9PubMed Central. Risk of Ischemic and Hemorrhagic Stroke in Individuals With Type 1 and Type 2 Diabetes: A Nationwide Cohort Study in Sweden Separate research has estimated that diabetes roughly doubles the risk of ischemic stroke overall and increases hemorrhagic stroke risk by more than 50%.10Journal of Stroke. Diabetes and Stroke: What Are the Connections? Beyond occurrence, people with diabetes tend to have worse outcomes after a stroke, including higher mortality.11PubMed Central. Diabetes and Stroke: Epidemiology, Pathophysiology, Pharmaceuticals and Outcomes
Diabetes also affects the heart muscle directly, independent of blocked coronary arteries. Impaired glucose uptake by heart cells and disrupted energy production lead to stiffening of the heart muscle and abnormal relaxation patterns, a condition sometimes called diabetic cardiomyopathy. This can evolve into heart failure even in people with clean coronary arteries.12PubMed Central. Role of Diabetes Mellitus in Heart Failure With Preserved Ejection Fraction: A Review Article
Autonomic Neuropathy and the Gut
When people hear “nerve damage” in diabetes, they usually think of numb feet. But diabetes can also damage the autonomic nerves that control internal organs. Cardiovascular autonomic neuropathy affects heart rate regulation and blood pressure, and can cause dizziness on standing, abnormal heart rhythms, or silent heart attacks where the usual warning chest pain is absent. A study of people with type 2 diabetes attending a primary care center found cardiovascular autonomic neuropathy in about 15% of participants, with longer diabetes duration independently increasing the odds.13PLoS ONE. Prevalence of cardiovascular autonomic neuropathy and gastroparesis symptoms among patients with type 2 diabetes who attend a primary health care center
Autonomic nerve damage in the gut can cause gastroparesis, where the stomach empties too slowly. Symptoms include nausea, bloating, vomiting, and unpredictable blood sugar swings because food absorption becomes erratic. The same study found gastroparesis symptoms in roughly 6% of participants.14PLoS ONE. Prevalence of cardiovascular autonomic neuropathy and gastroparesis symptoms among patients with type 2 diabetes who attend a primary health care center Gastroparesis creates a frustrating feedback loop: unpredictable digestion makes blood sugar harder to manage, and poor blood sugar control worsens the nerve damage causing the problem.
The Brain, Dementia, and Cognitive Decline
Diabetes doubles the incidence of dementia, including both Alzheimer’s disease and vascular dementia. A population-based study with neuropathological data revealed something unexpected about how this happens. People with diabetes who developed dementia were actually less likely to have the classic brain plaques and tangles associated with Alzheimer’s, but significantly more likely to have brain infarcts, which are small areas of dead tissue from blocked blood vessels.15PubMed. Diabetes, Alzheimer disease, and vascular dementia: a population-based neuropathologic study This suggests that much of the cognitive decline in diabetes is driven by vascular injury to the brain rather than the amyloid pathway that dominates Alzheimer’s research. In practical terms, it means that the same strategies protecting the heart and kidneys, controlling blood sugar, blood pressure, and cholesterol, are likely the best defense against diabetes-related cognitive decline as well.
Liver Disease
The relationship between type 2 diabetes and non-alcoholic fatty liver disease runs in both directions: diabetes worsens liver disease progression, and worsening liver disease makes diabetes harder to control. The two conditions share underlying metabolic disturbances, including insulin resistance and chronic low-grade inflammation. When fatty liver disease advances to fibrosis and eventually cirrhosis, the liver’s ability to regulate glucose and lipids deteriorates further, compounding the metabolic dysfunction.16PubMed Central. NAFLD Fibrosis Progression and Type 2 Diabetes: The Hepatic-Metabolic Interplay Whether someone’s liver disease progresses or regresses depends on a mix of factors that interact over time, which is part of why some people with diabetes develop serious liver complications while others do not.
Immune Function and Infections
Persistently high blood sugar impairs the immune system at multiple levels. The function of key immune cells, including the ones that engulf bacteria and the ones that kill virus-infected cells, becomes sluggish in a high-glucose environment.17PubMed Central. Type 2 Diabetes and its Impact on the Immune System At the same time, chronic hyperglycemia triggers a persistent inflammatory response that paradoxically weakens immune defenses while keeping inflammation simmering.18Health Sciences Review. Deciphering the intricacies of immune system dysfunction and its impact on diabetes mellitus The result is a higher susceptibility to urinary tract infections, skin infections, fungal infections, respiratory infections, and slower wound healing. This is one reason skin infections are among the most common dermatological findings in people with diabetes, appearing in about one in five people with type 2 diabetes in one clinical survey. That same survey found skin lesions of some kind in over 60% of participants, with diabetic dermopathy, the brownish shin spots many people with diabetes notice, being present in roughly one in eight.19PubMed. Skin lesions in diabetes mellitus: prevalence and clinical correlations
Joints, Gums, and Sexual Health
AGE accumulation does not spare connective tissue. In people with long-standing type 1 diabetes, researchers found that joint stiffness in the hands, shoulders, and back was associated with higher long-term blood sugar levels and with specific AGEs measured in skin biopsies.20PubMed. Hand, shoulder and back stiffness in long-term type 1 diabetes; cross-sectional association with skin collagen advanced glycation end-products Conditions like frozen shoulder, trigger finger, and limited joint mobility are more common in people with diabetes than in the general population. The collagen in tendons and joint capsules essentially becomes stiffer and less flexible as AGEs cross-link the protein fibers.
Oral health is another area where diabetes creates a two-way problem. Diabetes increases the risk of periodontitis, the severe form of gum disease that destroys the tissue and bone supporting teeth. Periodontitis, in turn, worsens blood sugar control through systemic inflammation.21PubMed Central. Periodontitis and diabetes: a two-way relationship People with diabetes tend to develop more severe gum destruction, and those with untreated gum disease have a harder time achieving good glycemic control.22PubMed Central. Relationship between diabetes and periodontal infection Treating periodontitis can modestly improve blood sugar, making dental care a genuinely relevant part of diabetes management rather than a separate concern.
Sexual dysfunction is common but underreported. Erectile dysfunction occurs roughly three and a half times more frequently in men with diabetes than in men without, driven by the same combination of nerve damage and impaired blood flow that affects other organs.23PubMed Central. Erectile dysfunction and diabetes: A melting pot of circumstances and treatments Women with diabetes can also experience sexual dysfunction, including reduced arousal and discomfort, though this receives far less research attention.
Pregnancy Complications
Diabetes during pregnancy poses distinct risks for both mother and baby. Pre-existing diabetes (type 1 or type 2 present before conception) can increase the rate of congenital malformations, particularly affecting the heart, nervous system, and musculoskeletal system. Cardiac defects are up to five times more likely in infants of mothers with pre-existing diabetes, and they are associated with higher maternal blood sugar levels early in pregnancy when organs are forming.24PubMed. Fetal cardiac effects of maternal hyperglycemia during pregnancy The range of possible cardiac anomalies is wide, from structural defects like transposition of the great arteries to fetal cardiomyopathy.
Pre-existing diabetes can also cause excessively large babies, which increases birth injury risk, or in cases of severe maternal complications like nephropathy, can actually restrict fetal growth. Gestational diabetes, which develops during the second half of pregnancy, generally causes less severe versions of similar complications but still requires careful monitoring.25PubMed Central. Diabetes during Pregnancy: A Maternal Disease Complicating the Course of Pregnancy with Long-Term Deleterious Effects on the Offspring Optimizing blood sugar before and during early pregnancy is one of the most impactful steps for reducing the risk of birth defects.
Acute Emergencies
Not all diabetes complications develop gradually. Diabetic ketoacidosis and hyperosmolar hyperglycemic state are acute metabolic crises that can be life-threatening within hours. Ketoacidosis occurs when the body, starved of usable glucose, breaks down fat at a dangerous rate and produces acidic ketones. Hyperosmolar hyperglycemic state involves extreme blood sugar elevation and severe dehydration without significant ketone production. In reality, many patients present with features of both conditions simultaneously, which complicates diagnosis and treatment.26PubMed Central. Overlap of diabetic ketoacidosis and hyperosmolar hyperglycemic state Triggers often include missed insulin doses, infections, or other acute illnesses. These emergencies are preventable with consistent diabetes management but remain a significant cause of hospitalization and death, particularly in people with limited access to care.
Why Early Blood Sugar Control Matters Decades Later
One of the most striking findings in diabetes research is the legacy effect, sometimes called metabolic memory. In a landmark trial, participants randomized to tighter blood sugar control early in their disease continued to have fewer complications for decades afterward, even after the two study groups’ blood sugar levels converged within a year of the trial ending. The group that had better early control saw a 42% reduction in cardiovascular disease risk at 17 years of follow-up, and a 30% reduction that persisted for at least 30 years.27PubMed Central. The legacy effect in diabetes: are there long-term benefits? The microvascular benefits appeared even earlier and also lasted. This finding underscores that the damage from prolonged high blood sugar is not entirely reversible. Getting glucose under control early writes a protective code into the body’s vascular biology that pays dividends for decades.
Newer Medications That Protect Beyond Blood Sugar
For years, diabetes treatment focused almost exclusively on lowering blood sugar numbers, with the assumption that complications would follow. Two newer drug classes have changed that thinking by showing organ-protective effects that go beyond glucose control. SGLT2 inhibitors, which work by causing the kidneys to excrete excess glucose, have demonstrated clear benefits for kidney function and heart failure risk. GLP-1 receptor agonists, which mimic a gut hormone that regulates blood sugar, reduce the risk of heart attack, stroke, and cardiovascular death. A systematic review and meta-analysis found that GLP-1 receptor agonists reduced major adverse cardiovascular events by about 21% and also slowed kidney function decline.28PubMed. Cardiovascular, Kidney, and Safety Outcomes With GLP-1 Receptor Agonists Alone and in Combination With SGLT2 Inhibitors in Type 2 Diabetes
Both drug classes appear to work through anti-inflammatory and hemodynamic mechanisms in addition to their glucose-lowering effects. SGLT2 inhibitors may be particularly effective at reducing the kidney hyperfiltration described earlier, while GLP-1 receptor agonists seem to be stronger at reducing protein leakage in urine and atherosclerotic events like heart attack and stroke.29PubMed Central. SGLT2 Inhibitors and GLP-1 Receptor Agonists in Diabetic Kidney Disease: Evolving Evidence and Clinical Application Head-to-head comparisons in real-world data have found that SGLT2 inhibitors may have a modest edge in slowing the decline of kidney filtration rate, while major cardiovascular events, mortality, and heart failure hospitalization rates are broadly similar between the two classes.30PubMed. Kidney and Cardiovascular Effectiveness of SGLT2 Inhibitors vs GLP-1 Receptor Agonists in Type 2 Diabetes The cardiovascular benefits of GLP-1 receptor agonists appear consistent whether or not someone is also taking an SGLT2 inhibitor, suggesting the two classes work through complementary pathways and can be used together.31PubMed. Cardiovascular, Kidney, and Safety Outcomes With GLP-1 Receptor Agonists Alone and in Combination With SGLT2 Inhibitors in Type 2 Diabetes This shift toward medications that directly protect the heart and kidneys, rather than simply managing a number on a lab report, represents a genuine change in how diabetes complications are being prevented.